Probing for congenital nasolacrimal duct obstruction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Probing for Congenital Nasolacrimal Duct Obstruction." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435535/all/Probing_for_congenital_nasolacrimal_duct_obstruction.
Probing for congenital nasolacrimal duct obstruction. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435535/all/Probing_for_congenital_nasolacrimal_duct_obstruction. Accessed December 3, 2024.
Probing for congenital nasolacrimal duct obstruction. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435535/all/Probing_for_congenital_nasolacrimal_duct_obstruction
Probing for Congenital Nasolacrimal Duct Obstruction [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435535/all/Probing_for_congenital_nasolacrimal_duct_obstruction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Probing for congenital nasolacrimal duct obstruction
ID - 435535
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435535/all/Probing_for_congenital_nasolacrimal_duct_obstruction
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -